|
US3219656A
(en)
|
1963-08-12 |
1965-11-23 |
Rohm & Haas |
Alkylpolyalkoxyalkyl glucosides and process of preparation therefor
|
|
US3839318A
(en)
|
1970-09-27 |
1974-10-01 |
Rohm & Haas |
Process for preparation of alkyl glucosides and alkyl oligosaccharides
|
|
AT382381B
(de)
|
1984-10-02 |
1987-02-25 |
Oesterr Zuckerfab Evidenz |
Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate
|
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
|
US5661130A
(en)
|
1993-06-24 |
1997-08-26 |
The Uab Research Foundation |
Absorption enhancers for drug administration
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
US5773647A
(en)
|
1997-02-07 |
1998-06-30 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
EP1062240B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
|
JP2002512175A
(ja)
|
1998-02-27 |
2002-04-23 |
ノボ ノルディスク アクティーゼルスカブ |
Ｇｌｐ−１類似体の誘導体類
|
|
EP1061946B1
(en)
|
1998-02-27 |
2004-04-28 |
Novo Nordisk A/S |
Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
|
|
JP2003522099A
(ja)
|
1998-02-27 |
2003-07-22 |
ノボ ノルディスク アクティーゼルスカブ |
遅延作用プロファイルを有するｇｌｐ−１のｇｌｐ−１誘導体及びエキセンジン
|
|
EP1175390B1
(en)
|
1999-04-05 |
2005-02-02 |
Emisphere Technologies, Inc. |
Disodium salts, monohydrates, and ethanol solvates
|
|
KR101241862B1
(ko)
|
2003-09-19 |
2013-03-13 |
노보 노르디스크 에이/에스 |
신규 ｇｌｐ-1 유도체
|
|
MXPA06006745A
(es)
|
2003-12-18 |
2006-08-18 |
Novo Nordisk As |
Compuestos glp-1 novedosos.
|
|
JP2007537142A
(ja)
|
2003-12-18 |
2007-12-20 |
ノボ ノルディスク アクティーゼルスカブ |
アルブミン様物質に結合した新規のｇｌｐ−１類似物
|
|
MXPA06015049A
(es)
|
2004-07-08 |
2007-02-08 |
Novo Nordisk As |
Marcadores prolongadores de polipeptidos que comprenden una porcion tetrazol.
|
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
|
US8030273B2
(en)
|
2004-10-07 |
2011-10-04 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
|
US7893017B2
(en)
|
2004-10-07 |
2011-02-22 |
Novo Nordisk A/S |
Protracted GLP-1 compounds
|
|
JP5755398B2
(ja)
|
2005-03-18 |
2015-07-29 |
ノヴォ ノルディスク アー／エス |
伸長されたｇｌｐ−１化合物
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
US20090318353A1
(en)
|
2006-08-25 |
2009-12-24 |
Novo Nordisk A/S |
Acylated Exendin-4 Compounds
|
|
WO2009030774A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Truncated glp-1 derivatives and their therapeutical use
|
|
US20100261637A1
(en)
|
2007-09-05 |
2010-10-14 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
EP2190872B1
(en)
|
2007-09-05 |
2018-03-14 |
Novo Nordisk A/S |
Glucagon-like peptide-1 derivatives and their pharmaceutical use
|
|
RU2548807C2
(ru)
|
2009-05-20 |
2015-04-20 |
Торэй Индастриз, Инк. |
Пептиды, проникающие в клетку
|
|
ES2659442T3
(es)
|
2009-09-30 |
2018-03-15 |
Thiomatrix Forschungs- Und Beratungs Gmbh |
Polímeros mucoadhesivos con estructuras parciales de vitamina B
|
|
WO2011133198A1
(en)
|
2010-04-21 |
2011-10-27 |
Hosheng Tu |
A pharmaceutical composition of nanoparticles
|
|
GB2501219A
(en)
|
2011-02-04 |
2013-10-16 |
Aegis Therapeutics Llc |
Orally bioavailable peptide drug compositions and methods thereof
|
|
WO2012140155A1
(en)
|
2011-04-14 |
2012-10-18 |
Novo Nordisk A/S |
Fatty acid acylated amino acids for oral peptide delivery
|
|
SG11201402400YA
(en)
*
|
2011-11-30 |
2014-06-27 |
Takeda Pharmaceutical |
Dry coated tablet
|
|
JP6228187B2
(ja)
|
2012-05-03 |
2017-11-08 |
ジーランド ファーマ アクティーゼルスカブ |
Ｇｉｐ−ｇｌｐ−１デュアルアゴニスト化合物及び方法
|
|
EP2861220A2
(en)
|
2012-06-14 |
2015-04-22 |
Entrega, Inc. |
Mucoadhesive devices for delivery of active agents
|
|
US20150273069A1
(en)
*
|
2012-10-17 |
2015-10-01 |
Novo Nordisk A/S |
Fatty acid acylated amino acids for oral peptide delivery
|
|
WO2015086733A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Dual glp-1/glucagon receptor agonists
|
|
WO2015086728A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
|
|
TW201625668A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
|
|
US10570184B2
(en)
|
2014-06-04 |
2020-02-25 |
Novo Nordisk A/S |
GLP-1/glucagon receptor co-agonists for medical use
|
|
US10265384B2
(en)
*
|
2015-01-29 |
2019-04-23 |
Novo Nordisk A/S |
Tablets comprising GLP-1 agonist and enteric coating
|
|
CN105832691B
(zh)
*
|
2016-05-31 |
2018-10-02 |
深圳市健元医药科技有限公司 |
一种度拉糖肽结肠定位缓释制剂及其制备方法
|
|
US20200237875A1
(en)
*
|
2019-01-30 |
2020-07-30 |
Synlev Pharmaceuticals Corporation |
Formulations and methods for treatment of fibromyalgia and related myofascial pain disorders
|